BioSpace News Archive

MGI Tech Co. Ltd. (MGI), a global life science leader and innovator, has been awarded Gold by Instrument Business Outlook (IBO) at the 2022 IBO Design Awards for the outstanding design and functionality of its DNBelab C4 Pocket Single-Cell Lab.

San Antonio-based medical device start-up Hera Biotech has closed an oversubscribed $1.9 million seed financing round to support the company’s commercialization strategy for its category-defining non-surgical diagnostic test for endometriosis, MetriDx™.

The ePharmacy market is growing at a rapid pace on the back of a growing number of technology-savvy consumers, improving digitization in healthcare services, and increasing penetration of internet connectivity at the global platform.

LumaBridge (formerly known as Cancer Insight) and the Parker Institute for Cancer Immunotherapy (PICI), the largest network of immuno-oncology expertise in the world, have announced a new strategic partnership aimed at accelerating breakthrough immunotherapies from bench to bedside with greater ease.

Consistent Initiatives For Research On Rare Diseases, And The High Cost Of In-House Drug Development Are Expected To Boost The Growth Of The Market By 10.1% CAGR During Forecast Period

Technological Innovations Leading To An Increase In Number Of New Product Launches Will Stimulate The Vascular Closure Device Market Expansion

Wilmington, Delaware, United States, Transparency Market Research Inc. - The global chest drainage system market is expected to gain impetus from the increasing cases of cardiovascular diseases and the need for pleural cavity drainage.

Clearmind Medicine Inc. (CSE: CMND), (OTC Pink: CMNDF), (FSE: CWY0) (“Clearmind” or the “company”), a biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major undertreated health problems, today announced additional positive pre-clinical results for treatment for cocaine addiction using MEAI, its novel psychedelic molecule.

Wilmington, Delaware, United States, Transparency Market Research Inc. - The global osteoporosis testing market is likely to gain from the increasing cases of osteoporosis worldwide.

Wilmington, Delaware, United States, Transparency Market Research Inc. - The rising prevalence of cognitive deficits and human malignancies in Alzheimer’s disease and Down Syndrome stands as a key factor aiding in expansion of the global dual specificity tyrosine phosphorylation regulated kinase 1A market during the forecast period, 2020 to 2030